FDA inspection
GBS Commonwealth Co., Ltd.: FDA inspection ending Feb 20, 2020
FDA inspection 1118348 · Official Action Indicated (OAI) · Geumcheon
Key facts
| Inspection ID | 1118348 |
|---|---|
| Firm | GBS Commonwealth Co., Ltd. |
| FEI number | 3015136700 |
| Address | #309 Woolim Lions Valley C, 168 Gasandijiteol1-Ro |
| City | Geumcheon |
| Country | Korea (the Republic of) |
| Fiscal year | 2020 |
| Inspection end date | Feb 20, 2020 |
| Classification | Official Action Indicated (OAI) |
| Project area | Compliance: Devices |
| Product type | Devices |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data